M1412 Met nsclc with egfr alk oth ab
Also known as: EGFR/ALK positive NSCLC, molecular mutation NSCLC, met nsclc w/ egfr alk
Performance measure documenting metastatic non-small cell lung cancer with sensitizing EGFR or ALK mutations or other actionable aberrations. Captures molecularly-driven treatment eligibility.
In Plain Language
Lung cancer with specific genetic mutations; Cancer caused by growth gene mutations
Clinical Context
Documents presence of sensitizing EGFR, ALK, ROS1, or NTRK mutations in metastatic non-small cell lung cancer, indicating targeted therapy eligibility.
RVU Information
CPT M1412 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
M-codes cover quality measures and performance reporting. They are used in value-based care programs to track whether specific clinical actions were taken. Documentation must support that the measured action was performed or a valid exclusion applies.
Specialties
Frequently Asked Questions
What is CPT code M1412?
CPT M1412 (Met nsclc with egfr alk oth ab) is a M Codes code. Performance measure documenting metastatic non-small cell lung cancer with sensitizing EGFR or ALK mutations or other actionable aberrations. Captures molecularly-driven treatment eligibility.
Is M1412 covered by insurance?
M1412 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Documents presence of sensitizing EGFR, ALK, ROS1, or NTRK mutations in metastatic non-small cell lung cancer, indicating targeted therapy eligibility.
When is CPT M1412 used?
Documents presence of sensitizing EGFR, ALK, ROS1, or NTRK mutations in metastatic non-small cell lung cancer, indicating targeted therapy eligibility.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.